Depakote ER Related Published Studies
Well-designed clinical trials related to Depakote ER (Divalproex)
Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population. [2008.02]
Divalproex in the treatment of acute bipolar depression: a preliminary double-blind, randomized, placebo-controlled pilot study. [2007.12]
Divalproex Sodium for the Treatment of PTSD and Conduct Disordered Youth: A Pilot Randomized Controlled Clinical Trial. [2007.10]
A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania. [2007.07]
Double-blind, placebo-controlled trial of divalproex monotherapy in the treatment of symptomatic youth at high risk for developing bipolar disorder. [2007.05]
Efficacy profiles of psychopharmacology: divalproex sodium in conduct disorder. [2006.09]
Reduced suicidal ideation in bipolar I disorder mixed-episode patients in a placebo-controlled trial of olanzapine combined with lithium or divalproex. [2006.08]
Comparative absorption profiles of divalproex sodium delayed-release versus extended-release tablets -- clinical implications. [2006.04]
Divalproex sodium vs. placebo in the treatment of repetitive behaviours in autism spectrum disorder. [2006.04]
Every-12-hour administration of extended-release divalproex in patients with epilepsy: impact on plasma valproic acid concentrations. [2006.03]
A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania. [2006.03]
A randomized, double-blind, placebo-controlled pilot trial of safety and tolerability of two doses of divalproex sodium in outpatients with probable Alzheimer's disease. [2005.12]
Divalproex sodium in nursing home residents with possible or probable Alzheimer Disease complicated by agitation: a randomized, controlled trial. [2005.11]
A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder. [2005.11]
Relationship of mania symptomatology to maintenance treatment response with divalproex, lithium, or placebo. [2005.10]
Effect of divalproex on metabolic parameters is dose related in migraine prophylaxis. [2005.09]
Once-a-day extended-release dosage form of divalproex sodium III: development and validation of a Level A in vitro-in vivo correlation (IVIVC). [2005.09]
Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial. [2005.06]
Divalproex sodium for pediatric mixed mania: a 6-month prospective trial. [2005.06]
Double-blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. [2005.05]
Service utilization and costs of olanzapine versus divalproex treatment for acute mania: results from a randomized, 47-week clinical trial. [2005.04]
Divalproex in the treatment of bipolar depression: a placebo-controlled study. [2005.04]
Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder. [2005.03]
Extended-release divalproex in child and adolescent outpatients with epilepsy. [2005.03]
Lower effectiveness of divalproex versus valproic acid in a prospective, quasi-experimental clinical trial involving 9,260 psychiatric admissions. [2005.02]
Divalproex sodium in the management of post-herpetic neuralgia: a randomized double-blind placebo-controlled study. [2005.01]
Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium. [2005.01]
Topiramate and divalproex in combination with risperidone for acute mania: a randomized open-label study. [2005.01]
Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania. [2004.12]
Pharmacokinetics and safety of extended-release divalproex sodium tablets: morning versus evening administration. [2004.11.01]
Comparison of the bioavailability of 250 and 500 mg divalproex sodium extended-release tablets in healthy volunteers. [2004.11]
Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study. [2004.06]
Adjunctive divalproex and hostility among patients with schizophrenia receiving olanzapine or risperidone. [2004.03]
Pharmacotherapy for marijuana dependence: a double-blind, placebo-controlled pilot study of divalproex sodium. [2004.01]
Risperidone does not affect steady-state pharmacokinetics of divalproex sodium in patients with bipolar disorder. [2004]
Divalproex sodium for the treatment of conduct disorder: a randomized controlled clinical trial. [2003.10]
Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study. [2003.07]
Maintenance efficacy of divalproex in the prevention of bipolar depression. [2003.07]
The safety and early efficacy of oral-loaded divalproex versus standard-titration divalproex, lithium, olanzapine, and placebo in the treatment of acute mania associated with bipolar disorder. [2003.07]
Once-a-day controlled-release dosage form of divalproex sodium I: formulation design and in vitro/in vivo investigations. [2003.06]
Divalproex in the treatment of impulsive aggression: efficacy in cluster B personality disorders. [2003.06]
Divalproex sodium versus olanzapine in the treatment of acute mania in bipolar disorder: health-related quality of life and medical cost outcomes. [2003.03]
Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia. [2003.01]
A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder. [2002.12]
The use of divalproex in alcohol relapse prevention: a pilot study. [2002.08.01]
Divalproex extended-release versus the original divalproex tablet: results of a randomized, crossover study of well-controlled epileptic patients with primary generalized seizures. [2002.08]
A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis. [2002.06.11]
Olanzapine versus divalproex in the treatment of acute mania. [2002.06]
Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: a double-blind placebo-controlled pilot study. [2002.05]
Pattern of response to divalproex, lithium, or placebo in four naturalistic subtypes of mania. [2002.04]
Comparison of the bioavailability of unequal doses of divalproex sodium extended-release formulation relative to the delayed-release formulation in healthy volunteers. [2002.03]
Divalproex sodium (Depakote) for alcohol withdrawal and relapse prevention. [2002]
Divalproex therapy in medication-naive and mood-stabilizer-naive bipolar II depression. [2001.12]
Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial. [2001.09]
[Prediction of treatment response in acute mania: controlled clinical trials with divalproex] [2001.05]
A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder. [2001.03]
Placebo-controlled study of divalproex sodium for agitation in dementia. [2001.01]
Effects of divalproex versus lithium on length of hospital stay among patients with bipolar disorder. [2000.09]
Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. [2000.06]
Randomized, placebo-controlled pilot study of divalproex sodium in the treatment of acute exacerbations of chronic schizophrenia. [2000.06]
A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. [2000.05]
Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design. [2000.05]
Safety and tolerability of oral loading divalproex sodium in acutely manic bipolar patients. [1999.12]
Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania. [1999.08]
A comparison of divalproex with propranolol and placebo for the prophylaxis of migraine without aura. [1997.09]
Divalproex sodium in migraine prophylaxis: a dose-controlled study. [1997.04]
A pilot study of lithium carbonate plus divalproex sodium for the continuation and maintenance treatment of patients with bipolar I disorder. [1997.03]
Safety and efficacy of divalproex sodium monotherapy in partial epilepsy: a double-blind, concentration-response design clinical trial. Depakote Monotherapy for Partial Seizures Study Group. [1997.01]
Depression during mania. Treatment response to lithium or divalproex. [1997.01]
Maintenance clinical trials in bipolar disorder: design implications of the divalproex-lithium-placebo study. [1997]
Effect size of efficacy measures comparing divalproex, lithium and placebo in acute mania. [1997]
Pharmacokinetic interactions and side effects resulting from concomitant administration of lithium and divalproex sodium. [1996.05]
A randomized, blinded, placebo-controlled trial of divalproex sodium prophylaxis in adults with newly diagnosed brain tumors. [1996.04]
A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania. [1996.04]
Plasma GABA predicts acute response to divalproex in mania. [1996.02.15]
Efficacy and safety of add-on divalproex sodium in the treatment of complex partial seizures. The M88-194 Study Group. [1996.01]
Migraine prophylaxis with divalproex. [1995.03]
Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. [1994.03.23]
Well-designed clinical trials possibly related to Depakote ER (Divalproex)
A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode. [2008.09]
A limited number of 5-azacitidine cycles can be effective treatment in MDS. [2008.08.12]
Hyperandrogenism, ovulatory dysfunction, and polycystic ovary syndrome with valproate versus lamotrigine. [2008.08]
Valproate treatment of acute alcohol hallucinosis: a double-blind, placebo-controlled study. [2008.07]
Effect of valproic acid on body weight, food intake, physical activity and hormones: results of a randomized controlled trial. [2008.06.26]
Attention changes in epilepsy patients following 3-month topiramate or valproate treatment revealed by event-related potential. [2008.06]
Adjunctive lamotrigine for partial seizures in patients aged 1 to 24 months. [2008.05.27]
Cinnarizine in refractory migraine prophylaxis: efficacy and tolerability. A comparison with sodium valproate. [2008.04]
Cinnarizine in refractory migraine prophylaxis: efficacy and tolerability. A comparison with sodium valproate. [2008.04]
Valproate-induced thrombocytopenia: a prospective monotherapy study. [2008.03]
Valproate (depakine-chrono) in the acute treatment of outpatients with generalized anxiety disorder without psychiatric comorbidity: randomized, double-blind placebo-controlled study. [2008.03]
The effect of sodium valproate on chronic daily headache and its subgroups. [2008.02]
The cognitive effects of oxcarbazepine versus carbamazepine or valproate in newly diagnosed children with partial seizures. [2007.12]
Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder. [2007.12]
Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy. [2007.11]
Risperidone alone versus risperidone plus valproate in the treatment of patients with schizophrenia and hostility. [2007.11]
Lamotrigine extended-release as adjunctive therapy for partial seizures. [2007.10.16]
Intravenous sodium valproate versus diazepam infusion for the control of refractory status epilepticus in children: a randomized controlled trial. [2007.10]
Subcutaneous histamine versus sodium valproate in migraine prophylaxis: a randomized, controlled, double-blind study. [2007.10]
Reversible effects of antiepileptic drugs on reproductive endocrine function in men and women with epilepsy--a prospective randomized double-blind withdrawal study. [2007.10]
A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial. [2007.10]
Agomelatine adjunctive therapy for acute bipolar depression: preliminary open data. [2007.09]
Randomized study of intravenous valproate and phenytoin in status epilepticus. [2007.09]
|
